Axillary evaluation in ductal cancer <i>in situ</i> of the breast: challenging the diagnostic accuracy of clinical practice guidelines
Andreas Karakatsanis(Uppsala University), Peter Stålberg(Uppsala University Hospital), Ava Kwong(University of Hong Kong), Imad Mohammed, Fredrik Wärnberg(Uppsala University), Guyla Nagy, Theodoros Foukakis(Karolinska Institutet), Antonios Valachis(Örebro University Hospital), Petros Charalampoudis(Royal London Hospital), Staffan Eriksson(Uppsala University), Marie Sundqvist(Landstinget i Kalmar län), Rosa Di Micco, Lida Pistioli(University of Gothenburg), Roger Olofsson Bagge(Sahlgrenska University Hospital)
Cited by 3
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer
|Surgery|2006|379
External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms
|JAMA Oncology|2020|284
Long‐Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
|World Journal of Surgery|2011|256
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
|Nature Genetics|2014|246